Nuclear medicine in infectious diseases

Nuclear medicine in infectious diseases / Alberto Signore, Andor W.J.M. Glaudemans, editors.

This book is designed as a reference manual that is exceptional in systematically discussing every aspect of nuclear medicine imaging of infections, with careful explanation of the most up-to-date concepts and recent guidelines on diagnostic flowcharts as shared between the EANM, ESR, ESNR, ESCMID,...

Full description

Saved in:
Bibliographic Details
Other Authors: Signore, A. (Alberto), 1959-, Glaudemans, Andor W. J. M. (Andor Waltherus Johannes Maria), 1976-
Format: eBook
Language:English
Published: Cham, Switzerland : Springer, ©2020.
Subjects:
Nuclear medicine.
Communicable diseases > Imaging.
Nuclear medicine
Online Access:Click for online access
Table of Contents:
  • Intro; Foreword; Preface; Contents; 1: Infections: The Emergency of the New Millennium; 1.1 Introduction; 1.2 From Optimism to the Harsh Reality: The History of Infectious Diseases in the Past Century; 1.3 What Are Emerging Infectious Diseases (EIDs)?; 1.4 The New Millennium: Infectious Disease Threats; 1.5 The Healthcare-Associated Infections and Their Burden of Antimicrobial Resistance in the New Millennium; 1.6 Conclusions; References; 2: Gamma Camera Imaging of Infectious Diseases; 2.1 Clinically Validated and Commercially Available Radiopharmaceuticals
  • 2.1.1 111In-8-Hydroxyquinoline and 99mTc-Exametazime2.1.2 Gallium-67 Citrate; 2.1.3 99mTc-Besilesomab; 2.2 Experimental Radiopharmaceuticals; 2.2.1 99mTc-Ciprofloxacin; 2.2.2 99mTc-Ubiquicidin 29-41; 2.3 Future Perspectives and New Trends; References; 3: Radiopharmaceuticals for PET Imaging of Infection; 3.1 Introduction; 3.2 Clinically Validated/Tested and Commercially Available Radiopharmaceuticals; 3.2.1 [18F]FDG; 3.2.1.1 [18F]FDG and Different Microorganisms; 3.2.1.2 FDG Imaging of Some Site-Specific Infections Which Have Been Validated; Osteomyelitis; Spondylodiscitis
  • Diabetic FootHip and Knee Prosthesis; Infected Vascular Graft; Infective Endocarditis; Cardiac Implantable Electronic Device Infections; 3.2.2 Labeled White Blood Cells; 3.2.3 [68Ga]Citrate; 3.2.4 Peptides; 3.2.5 Ubiquicidin (UBI) Fragments; 3.3 Experimental Radiopharmaceuticals; 3.3.1 Peptides; 3.3.1.1 Depsipeptide Derivative; 3.3.1.2 K-A9 Peptide; 3.3.2 Antibiotics; 3.3.2.1 Ciprofloxacin; 3.3.2.2 Trimethoprim; 3.3.2.3 Puromycin; 3.3.2.4 Rifampicin; 3.3.2.5 Isoniazid; 3.3.2.6 Pyrazinamide; 3.3.2.7 Fluconazole; 3.3.3 Antibody Labeling
  • 3.3.3.1 Antibodies Against Gram-Negative Bacteria3.3.3.2 Antibodies Against Gram-Positive Bacteria; 3.3.3.3 Antibody Against Simian Immunodeficiency Virus Envelope Protein; 3.3.3.4 Aspergillus Fumigatus-Specific Monoclonal Antibody JF5; 3.3.4 Imaging Targeted Molecules or Metabolism Specific to Microorganisms; 3.3.4.1 Siderophores; 3.3.4.2 Carbohydrate Metabolism; 3.3.5 Other Metabolites; 3.3.5.1 Fialuridine (FIAU); 3.3.5.2 Para-Aminobenzoic acid (PABA); 3.3.5.3 d-Methionine; 3.3.5.4 Prothrombin; 3.3.5.5 Transferrin
  • 3.3.6 Nonspecific Tracers Used in Infection to Discriminate Infection from Malignancy3.3.6.1 [18F]fluorothymidine ([18F]FLT); 3.4 Conclusion and Future Perspective; References; 4: Hybrid SPECT/CT and PET/CT Imaging in Infectious Diseases; 4.1 Introduction; 4.2 SPECT/CT Characteristics; 4.2.1 Basic Concepts; 4.2.1.1 Planar Imaging; 4.2.1.2 SPECT and SPECT/CT; 4.2.2 Improved Anatomical Location; 4.2.3 Motion Correction and Iterative Reconstructions; 4.2.4 Attenuation and Scatter Correction; 4.2.5 Disadvantages; 4.2.6 Partial Volume Effects

Similar Items